Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Coagulation Factors and Inhibitors
Animal and experimental models
AT, HCII, serine protease inhibitors
Contact phase
Factor IX and vitamin K-dependent factors
Factor XIII
Factor VIII, factor V
Methods
Other coagulation factors and inhibitions
Procoagulant phospholipids
Protein C, protein S, thrombomodulin
Structural biology and drug design
Thrombin, thrombin receptors
Tissue factor, TFPI, factor VII
A naturally homozygous deletion mutation of LYS9 or LYS10 in the A-chain of alpha-thrombin reduces the catalytic efficiency of the enzyme
Akhavan S., De Cristofaro R., Peyvandi F., Mannucci P. M.
Anti-thrombotic effects of ER112787, a novel, nonpeptide thrombin receptor (PAR-1) antagonist, in a photochemically induced thrombosis model using guinea pigs
Matsuoka T., Kogushi M., Kobayashi H., Ono N., Kawata T., Kawahara T., Suzuki S., Hishinuma I.
Binding of minute amounts of thrombin to GPIbalpha accelerates early platelet reactions, but not the platelet procoagulant response
Ulrichts H., Keuren J., Vanhoorelbeke K., Wielders S., Feige M., Heemskerk J., Lindhout J., Deckmyn H.
Characterization of protein Kinase B/Akt activation and its role in thrombin and thrombin receptor-activating peptide-induced platelet activation
Kim S., Kunapali P.
Characterization of the interaction of alpha-thrombin with melagatran analogs with different P3 substituents: a kinetic and thermodynamic study
Deinum J., Gyzander E., Gustavsson L.
Comparison of fibrinogen and S2238 as substrates for the study of multiple, active thrombin forms in the process of plasma clotting
Pajdak W., Radwan J.
Differences in protease activated receptor-1 stimulation between vWF and P-selectin release in endothelial cells-implications of distinct signaling of Weibel–Palade release
Cleator J. H., Mazzoni M. R., Vaughan D. E., Hamm H. E.
Extrinsic pathway function, thrombin generation potential and perioperative blood loss in CABG surgery
Gruenewald M., Siegemund A., Goedjs O., Gallmeier G. U., Stiller P., Gruenewald A., Konegen A., Griesshammer M.
Factor XI-activation by thrombin on activated platelets requires both anion binding exosites I and II
Baglia F. A., Yun T. H., Myles T., Navaneetham D., Leung L. L. K., Walsh P.N.
Functional characterization of a naturally occurring homozygous Gly25Ser mutation in thrombin B chain
Akhavan S., Guillin M. C., Peyvandi F., Mannucci P. M., Bezeaud A.
Influence of selective nonpeptide PAR-1 and PAR-4 antagonists on thrombin-induced aggregation of human platelets
Simonet S., Rupin A., Coumailleau S., Henlin J. M., Fauchère J. L., Lavielle G., Verbeuren T. J.
M-thrombin (Tris-coupled thrombin) is a novel potent agonist of platelet activation with minimum effect on clot formation
Sakurai Y., Takeyama M., Shima M., Hosokawa K., Kasuda S., Nishiya K., Koide T., Yoshioka A.
Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow by activating fibrinogen-adherent platelets
Diamond S., Goel M.
Pepducin-based intervention of platelet signaling and systemic platelet activation
Covic L., Kuliopulos A.
Phenotypic thrombin generation: a composite view
Brummel K. E., Pouliot R. L., Mann K. G.
Plasmin-mediated activation of platelets occurs through interaction with PAR-4
Quinton T., Kunapuli S. P.
Prenatal diagnosis of dysprothrombinemia in an Iranian family
Hong S. H., Lotfi V., Peyvandi P., Lak M., Zeinali S.
Rapid and automated quantification of the kinetics of thrombin formation using the Thrombin Dynamics Test (TDT)
Calatzis A., Reininger A. J., Spannagl A., Schramm W.
Recombinant FVIIa: correction of thrombocytopenic defects in whole blood clotting model
Yeo E., Miscevic N.
Recombinant Lopap (a prothrombin activator from Lonomia obliqua) has a very conservative structure of lipocalins
Reis C. V., Fritzen M., Ho P. L., Junqueira-De-Azevedo I. L. M., Schattner M., Chudzinski-Tavassi A. M.
Role of the tissue factor-thrombin pathway in endotoxemia
Pawlinski R., Pedersen B., Mackman N.
Roles of autolytic loop-2 and at Asp554 of human prothrombin in the specificity of meizothrombin
Koike H., Morita T.
Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation: competition for cofactor sites on thrombin determines its fate
Philippou H., Rance J., Myles T., Hall S. W., Ariens R. A. S., Grant P. J., Leung L., Lane D. A.
Synthesis of arginine-containing peptides and study on their effects upon thrombin
Kibirev V. K., Poyarkova S. A., Gershkovich A. A.
The interaction of the 268–282 region of GpIba with the heparin binding site of thrombin inhibits the enzyme activation of Factor VIII
De Cristofaro R., De Filippis V.
The molecular basis of thrombin allostery revealed by a 1.8-Å structure of the ‘slow’ form
Huntington J., Esmon C. T.
Thrombin binding to GPIba induces platelet adhesion, aggregation and fibrin clot retraction supported by resting a Iibb 3 interaction with polymerized fibrin
Dubois C., Steiner B., Meyer Reigner S. C.
Thrombin causes an inflammatory cytokine response, which is inhibited by protein C, in both primary human monocytes and a monocyte (THP-1) cell line
Hodgson A., Hochart H., Murphy C. V., Livingstone W., Smith O. P.
Thrombin receptors on the cells of the blood–brain barrier
Bartha K., Vajda S., Kollár A., Machovich R., Adam V.
Thrombin-mediated Ca2+ responses in chick embryo cardiomyocytes and cardiofibroblasts
Strukova S., Ide J., Aoki T., Glusa E., Ishiwata S.
Tyrosine kinases regulate the activation of phosphatidylinositol 3-kinase in platelets stimulated by the PAR1-activating peptide
Lassila R., Kroll M. H., Reséndiz J. C.